Persistent Asset Partners »

Kailera Therapeutics shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Kailera Therapeutics shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Kailera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kailera Therapeutics held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kailera Therapeutics by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $39k 1.8k 22.03

More positions owned by Persistent Asset Partners

Intel Corporation Call Option (INTC)
Kla Corp Com New Call Option (KLAC)
Nebius Group Shs Class A Call Option (NBIS)
Kodiak Sciences Call Option (KOD)
Novo-nordisk A S Adr Put Option (NVO)
Corning Incorporated Call Option (GLW)
Vaxcyte Call Option (PCVX)
Micron Technology Call Option (MU)
Monte Rosa Therapeutics Call Option (GLUE)
Robinhood Mkts Com Cl A (HOOD)
Arcus Biosciences Incorporated Call Option (RCUS)
Stmicroelectronics N V Ny Registry (STM)
Uniqure Nv SHS Call Option (QURE)
Amphenol Corp Cl A (APH)
Marvell Technology Call Option (MRVL)

View all positions for Persistent Asset Partners

Top funds holding Kailera Therapeutics

Bain Capital Investors
Bain Capital Life Sciences Investors
Rtw Investments
Canada Pension Plan Investment Board
Atlas Venture Life Science Advisors
FMR
BlackRock
Citadel Advisors
Adage Capital Partners GP
Wellington Management Company
Royalty Pharma Sub-Manager
Siren
Vanguard Capital Management
Vanguard Portfolio Management
Geode Capital Management

View all funds holding Kailera Therapeutics